|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and cash-equivalents | ||||||||||||||||||||
| Oaktree Capital Group Excluding Consolidated Funds | ||||||||||||||||||||
| Consolidated VIEs | ||||||||||||||||||||
| U.S. Treasury and other securities | ||||||||||||||||||||
| Investments | ||||||||||||||||||||
| Oaktree Capital Group Excluding Consolidated Funds | ||||||||||||||||||||
| Consolidated VIEs | ||||||||||||||||||||
| Due from affiliates | ||||||||||||||||||||
| Other assets, net | ||||||||||||||||||||
| Oaktree Capital Group Excluding Consolidated Funds | ||||||||||||||||||||
| Consolidated VIEs | ||||||||||||||||||||
| Dividends and interest receivable | ||||||||||||||||||||
| Due from brokers | ||||||||||||||||||||
| Receivable for securities sold | ||||||||||||||||||||
| Derivative assets, at fair value | ||||||||||||||||||||
| Consolidated VIEs | ||||||||||||||||||||
| Total derivative assets, at fair value | ||||||||||||||||||||
| Consolidated VIEs | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Unitholders’ Capital | ||||||||||||||||||||
| Liabilities: | ||||||||||||||||||||
| Accrued compensation expense | ||||||||||||||||||||
| Accounts payable, accrued expenses and other liabilities | ||||||||||||||||||||
| Oaktree Capital Group Excluding Consolidated Funds | ||||||||||||||||||||
| Consolidated VIEs | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Debt obligations (Note 9) | ||||||||||||||||||||
| Oaktree Capital Group Excluding Consolidated Funds | ||||||||||||||||||||
| Consolidated VIEs | ||||||||||||||||||||
| Payables for securities purchased | ||||||||||||||||||||
| Derivative liabilities, at fair value | ||||||||||||||||||||
| Consolidated VIEs | ||||||||||||||||||||
| Total derivative liabilities, at fair value | ||||||||||||||||||||
| Distributions payable | ||||||||||||||||||||
| Debt obligations of the consolidated funds | ||||||||||||||||||||
| Oaktree Capital Group Excluding Consolidated Funds | ||||||||||||||||||||
| Consolidated VIEs | ||||||||||||||||||||
| Total debt obligations of the consolidated funds | ||||||||||||||||||||
| Consolidated VIEs | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Non-controlling redeemable interests in consolidated funds | ||||||||||||||||||||
| Unitholders’ capital: | ||||||||||||||||||||
| Preferred units | ||||||||||||||||||||
| Series A Preferred Units | ||||||||||||||||||||
| Series B Preferred Units | ||||||||||||||||||||
| Common units | ||||||||||||||||||||
| Paid-in capital | ||||||||||||||||||||
| Retained earnings (accumulated deficit) | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Unitholders’ capital attributable to Brookfield Oaktree Holdings, LLC | ||||||||||||||||||||
| Non-controlling interests in consolidated subsidiaries | ||||||||||||||||||||
| Total non-controlling interests in consolidated subsidiaries | ||||||||||||||||||||
| Total unitholders’ capital | ||||||||||||||||||||
| Total liabilities and unitholders’ capital | ||||||||||||||||||||
Loading...